60 Participants NeededMy employer runs this trial

REACH+ for Anorexia Nervosa

(REACH+ Trial)

JS
Overseen ByJoanna Steinglass, MD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: New York State Psychiatric Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to find the best combination of treatments to prevent relapse in individuals with anorexia nervosa after hospital discharge. Researchers test various methods, such as challenging negative thoughts, using personal motivations, and learning from recovery stories. The goal is to determine which approach most effectively maintains healthy behaviors and prevents weight loss. This study is part of the "Relapse Prevention and Changing Habits" program. Individuals diagnosed with anorexia nervosa who have reached a stable weight and can use the internet for video calls may be suitable participants. As an unphased trial, this study offers a unique opportunity to contribute to innovative strategies for long-term recovery.

Will I have to stop taking my current medications?

You may need to stop taking certain medications, especially if they affect weight, like stimulants, olanzapine, or mirtazapine. Antidepressants are allowed, but daily psychotropic medications other than these are not permitted.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the treatment method called Relapse Prevention and Changing Habits (REACH+) is being developed to help individuals with anorexia nervosa avoid reverting to old habits after treatment. Previous studies on similar behavioral treatments have found them to be generally well-received by patients. These treatments focus on changing thoughts about eating and help build new, healthier habits.

The REACH+ method involves discussing eating habits, challenging unhelpful thoughts, and identifying personal motivations for recovery. It also includes progress checks in short sessions, often conducted via video calls. Notably, participants do not need to maintain daily food logs, which many find relieving.

Although this study lacks specific safety data, treatments like this are typically safe because they focus on behavior and thinking patterns rather than medication. Overall, the approach is designed to be supportive and flexible, aiding individuals in maintaining recovery without causing harm.12345

Why are researchers excited about this trial?

Researchers are excited about the new approaches in treating anorexia nervosa because they focus on relapse prevention and changing habits, which are different from traditional methods like nutritional rehabilitation and cognitive-behavioral therapy. These new treatments emphasize personalized motivators and narratives, helping patients identify what drives their recovery while integrating lived experiences from others. Some methods include in-session eating experiments, mindful acceptance of thoughts, and the use of food logs tailored to individual needs, offering a more holistic and flexible approach than standard therapies. By targeting distorted thoughts and focusing on the broader identity beyond the eating disorder, these treatments could offer a more sustainable path to recovery.

What evidence suggests that this trial's treatments could be effective for AN?

Research has shown that people with anorexia nervosa often experience a return of symptoms, even after gaining weight. Studies indicate that between 35% and 41% of individuals may relapse within 18 months. The Relapse Prevention and Changing Habits (REACH+) approach, which participants in this trial may receive, aims to address this by focusing on changing harmful habits associated with anorexia. This method uses insights from brain science to help retrain the brain's habit patterns, supporting long-term recovery. Early results suggest that focusing on these habits might improve recovery outcomes for those with anorexia nervosa.12356

Are You a Good Fit for This Trial?

This trial is for people who were recently treated in the hospital for anorexia nervosa, have regained weight (BMI over 19), are medically stable, can use video calls, and aren't taking certain medications or dealing with other serious health issues. They can't join if they're pregnant, at risk of suicide, or need specialized treatment for another disorder.

Inclusion Criteria

Weight restored (BMI > 19 kg/m2) at New York State Psychiatric Institute
You are in good health and not currently experiencing any major medical issues.
Internet capability with videoconferencing
See 1 more

Exclusion Criteria

You are taking medications that affect your mind, except for antidepressants. Some medications that can cause weight gain, such as stimulants, olanzapine, and mirtazapine, are not allowed.
You are at high risk of harming yourself.
You are pregnant.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preparation Phase

Examination of accessibility and feasibility of the treatment package with 10 participants

Not specified

Optimization Phase

Testing of treatment components for weight maintenance after acute treatment

6 months
Regular sessions (face-to-face via video)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Relapse Prevention and Changing Habits

Trial Overview

The study is testing a program called REACH+ to help prevent relapse after hospitalization for anorexia nervosa. It looks at which parts of the program best support staying healthy and maintaining weight using online sessions.

How Is the Trial Designed?

26

Treatment groups

Experimental Treatment

Group I: Talk, Change, Motivation through Values, Check-Ins, Short-Term Food LogsExperimental Treatment1 Intervention
Group II: Talk, Change, Motivation through Values, Check-Ins, No Food LogsExperimental Treatment1 Intervention
Group III: Talk, Change, Motivation through Narratives, Sessions, Short-Term Food LogsExperimental Treatment1 Intervention
Group IV: Talk, Change, Motivation through Narratives, Sessions, No Food LogsExperimental Treatment1 Intervention
Group V: Talk, Change, Motivation through Narratives, Check-Ins, Long-Term Food LogsExperimental Treatment1 Intervention
Group VI: Talk, Change, Motivation Through Values, Sessions, No Food LogsExperimental Treatment1 Intervention
Group VII: Talk, Change, Motivation Through Values, Sessions, Long-Term Food LogsExperimental Treatment1 Intervention
Group VIII: Talk, Accept, Motivation through Values, Sessions, Short-Term Food LogsExperimental Treatment1 Intervention
Group IX: Talk, Accept, Motivation through Values, Sessions, No Food LogsExperimental Treatment1 Intervention
Group X: Talk, Accept, Motivation through Values, Check-Ins, Long-Term Food LogsExperimental Treatment1 Intervention
Group XI: Talk, Accept, Motivation through Narratives, Sessions, Long-Term Food LogsExperimental Treatment1 Intervention
Group XII: Talk, Accept, Motivation through Narratives, Check-Ins, Short-Term Food LogsExperimental Treatment1 Intervention
Group XIII: Talk, Accept, Motivation through Narratives, Check-Ins, No Food LogsExperimental Treatment1 Intervention
Group XIV: Do, Change, Motivation through Values, Check-Ins, Long-Term Food LogsExperimental Treatment1 Intervention
Group XV: Do, Change, Motivation through Narratives, Check-Ins, Short-Term Food LogsExperimental Treatment1 Intervention
Group XVI: Do, Change, Motivation through Narratives, Check-Ins, No Food LogsExperimental Treatment1 Intervention
Group XVII: Do, Change, Motivation Through Values, Sessions, Short-Term Food LogsExperimental Treatment1 Intervention
Group XVIII: Do, Change, Motivation Through Values, Sessions, No Food LogsExperimental Treatment1 Intervention
Group XIX: Do, Change, Motivation Through Narratives, Sessions, Long-term Food LogsExperimental Treatment1 Intervention
Group XX: Do, Accept, Motivation through Values, Sessions, Short-Term Food LogsExperimental Treatment1 Intervention
Group XXI: Do, Accept, Motivation through Values, Check-Ins, Short-Term Food LogsExperimental Treatment1 Intervention
Group XXII: Do, Accept, Motivation through Values, Check-Ins, No Food LogsExperimental Treatment1 Intervention
Group XXIII: Do, Accept, Motivation through Narratives, Sessions, Short-Term Food LogsExperimental Treatment1 Intervention
Group XXIV: Do, Accept, Motivation through Narratives, Sessions, No Food LogsExperimental Treatment1 Intervention
Group XXV: Do, Accept, Motivation through Narratives, Check-Ins, Long-Term Food LogsExperimental Treatment1 Intervention
Group XXVI: Do, Accept, Motivation Through Values, Sessions, Long-Term Food Logs,Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York State Psychiatric Institute

Lead Sponsor

Trials
481
Recruited
154,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Brown University

Collaborator

Trials
480
Recruited
724,000+

Citations

Optimizing relapse prevention and changing habits (REACH+) ...

Relapse rates in anorexia nervosa (AN) are high, even after full weight restoration. This study aims to develop a relapse prevention treatment that specifically ...

Relapse Prevention and Changing Habits in Anorexia ...

This trial, Relapse Prevention and Changing Habits (REACH+), targets the habitual control of maladaptive behavior to support patients with AN in the 6 months ...

Optimizing relapse prevention and changing habits ...

Relapse rates in anorexia nervosa are high and no intervention has emerged as the treatment of choice to improve outcomes in adults.

Changing Habits in Anorexia: A New Approach to Recovery

Using neuroscience on habits and anorexia nervosa to develop and test new approaches to recovery.

Perspectives on relapse prevention following intensive ... - PMC

Relapse prevention is a critical treatment need for patients with anorexia nervosa, as this illness too often follows a protracted course.

5 Risk Signs of an Eating Disorder Relapse

Longitudinal cohort and treatment follow-up studies estimate that 20% to 50% of those with eating disorders will relapse. The risk of relapse is ...